Clinical advances in systemic lupus erythematosusJune 14, 2018
The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate exciting advances for individuals suffering from systemic lupus erythematosus (SLE).1,2 The first is a phase II clinical study of a promising oral treatment, baricitinib.1 The second demonstrates the effective use of the shingles vaccine* in SLE patients who are particularly prone to this infection.2
"Novel therapeutic strategies are needed for SLE, which causes significant morbidity and mortality, and so we are delighted to see the positive results from the phase II trial of baricitinib," said Professor Thomas Dörner, Chairperson of the Abstract Selection Committee, EULAR. "In addition, we welcome data on the vaccination of SLE patients against shingles, as currently there is considerable clinical uncertainty around this issue."
SLE is an autoimmune disease that is also referred to as lupus. It typically affects women between the ages of 15 and 50, and symptoms flare up unpredictably. SLE is caused by complicated interactions between the immune system and environmental factors leading to an imbalance in the way the immune system works. This imbalance causes inflammation which, if untreated, can lead to disability and a shortened lifespan. Different factors may trigger SLE in different people, and symptoms may vary considerably. In some the illness is never life-threatening but can cause chronic skin rashes or arthritis. Others develop potentially life-threatening disease in the kidneys, lungs or heart. Treatment of SLE traditionally involves non-specific anti-inflammatory or immunosuppressive medications. However, this approach is ineffective in many patients, and can be associated with many undesirable side effects.
Baricitinib provides significant clinical improvements with acceptable benefit/risk profile in SLE patients1
Baricitinib is an oral selective inhibitor of Janus kinase (JAK)1 and JAK2 which has been approved for the treatment of rheumatoid arthritis in Europe and Japan. In this phase II study, SLE patients taking baricitinib had a significant improvement in several clinical outcomes compared to placebo.1
"Our results demonstrated significant clinical improvements in SLE patients taking baricitinib versus placebo with an acceptable side effect profile," said Daniel Wallace, MD, FACP, MACR, Professor of Medicine, University of California-Los Angeles and Associate Director of the Rheumatology Fellowship Program at Cedars-Sinai Medical Center in Los Angeles, California. "We look forward to progressing baricitinib in further clinical studies as a promising new treatment for people suffering with SLE."
Current biologic agents for SLE target the B-cell due to the importance of autoantibodies in driving the origination and development of the disease. However, the interferon (IFN) pathway and other cytokines (such as IL-23, IL-12 and IL-2) have recently emerged as a promising therapeutic target. By targeting common components of the signalling cascade, such as the JAK-STAT pathway, there may be therapeutic advantages by more complete suppression of IFN and other cytokines in disease-related processes.3
This study included 314 patients with SLE receiving stable background therapy who were randomized 1:1:1 to placebo, baricitinib 2- or 4-mg once daily. Patients on baricitinib 4mg achieved significant resolution of arthritis or rash (SLEDAI-2K†) compared with placebo (67% vs 53%, p<0.05) which was the primary endpoint of the study. Patients on baricitinib 4mg also achieved a significantly greater SRI-4‡ response (64% vs 48%, p<0.05), as well as flare reduction (SFI§), improvement in Lupus Low Disease Activity State (LLDAS) and reduced tender joint count. Rates of adverse events leading to treatment discontinuation and serious adverse events (SAE) were higher for both baricitinib doses compared to placebo. There were no deaths, malignancies, major adverse cardiovascular events, tuberculosis, or serious herpes zoster infections; one SAE of deep vein thrombosis was reported in a patient with risk factors.1
Shingles vaccine well tolerated in patients with SLE2
Shingles, or herpes zoster (HZ), is a painful reactivation of varicella zoster virus which typically happens decades after an initial infection known as varicella or chickenpox. Patients with SLE are 10 times more likely to contract shingles compared to healthy individuals and it can also affect them at an earlier age.4 Although rarely life-threatening, shingles is associated with significant pain and associated morbidity and may lead to disruption or discontinuation of otherwise necessary immunosuppressant medications.
Specific guidelines about the use of the shingles vaccine in SLE patients have been lacking, largely due to a theoretical concern of vaccine-induced infection as well as the lack of clinical or experimental data upon which to base recommendations.4
"Our study showed that the live attenuated shingles vaccine was well tolerated and provoked an expected antibody response in stable SLE patients not receiving intensive immunosuppression," said Dr. C.C. Mok, Department of Medicine, Tuen Mun Hospital, Hong Kong (study author). "This is the first randomised controlled trial to study the shingles vaccine in individuals with SLE. We hope our results will inform guidelines and ultimately lead to the safe administration of the vaccine in appropriate SLE patients to reduce the burden of shingles in these individuals."
The study included 90 patients with stable SLE who were not receiving intensive immunosuppression. All participants had a history of HZ/chickenpox and were randomised to receive shingles vaccine or placebo. After six weeks antibody levels in the vaccine group increased by 59.8% versus a reduction of 2.1% in the control group (p=0.01) demonstrating the effect of the vaccine. Significance was maintained after adjustment for baseline value, lymphocyte count, immunoglobulin levels, SLEDAI**, and other clinical variables.2
No serious adverse events were reported. In the vaccine group, significantly more patients reported mild pain and redness at the injection site which subsided in a few days. None of the patients had clinical shingles infection post vaccination.2
Abstract number: OP0019 and OP0117
** Systemic Lupus Erythematosus Disease Activity Index.
† Systemic Lupus Erythematosus Disease Activity Index 2000.
‡ Systemic Lupus Erythematosus Responder Index.
§ SELENA-SLEDAI Flare Index.
NOTES TO EDITORS
For further information on this study, or to request an interview with the study lead, please do not hesitate to contact the EULAR Press Office:
Telephone: +44 (0) 20 7438 3084
YouTube: Eular Press Office
About Rheumatic and Musculoskeletal Diseases
Rheumatic and musculoskeletal diseases (RMDs) are a diverse group of diseases that commonly affect the joints but can affect any organ of the body. There are more than 200 different RMDs, affecting both children and adults. They are usually caused by problems of the immune system, inflammation, infections or gradual deterioration of joints, muscle and bones. Many of these diseases are long term and worsen over time. They are typically painful and Iimit function. In severe cases, RMDs can result in significant disability, having a major impact on both quality of life and life expectancy.5
About 'Don't Delay, Connect Today!'
'Don't Delay, Connect Today!' is a EULAR initiative that unites the voices of its three pillars; patient (PARE) organisations, scientific member societies and health professional associations - as well as its international network - with the goal of highlighting the importance of early diagnosis and access to treatment. In the European Union alone, over 120 million people are currently living with a rheumatic disease (RMD), with many cases undetected.6 The 'Don't Delay, Connect Today!' campaign aims to highlight that early diagnosis of RMDs and access to treatment can prevent further damage, and also reduce the burden on individual life and society as a whole.
The European League against Rheumatism (EULAR) is the European umbrella organisation representing scientific societies, health professional associations and organisations for people with RMDs. EULAR aims to reduce the burden of RMDs on individuals and society and to improve the treatment, prevention and rehabilitation of RMDs. To this end, EULAR fosters excellence in education and research in the field of rheumatology. It promotes the translation of research advances into daily care and fights for the recognition of the needs of people with RMDs by the EU institutions through advocacy action.
To find out more about the activities of EULAR, visit: http://www.eular.org.
1 Wallace DJ, Furie RA, Tanaka Y, et al. Baricitinib in systemic lupus erythematosus (SLE): results from a phase 2, randomized, double-blind, placebo-controlled study. EULAR 2018; Amsterdam: Abstract OP0019.
2 Mok CC, Chan KH, Ho LY, et al. Safety and immune response of a live attenuated herpes zoster vaccine in patients with systemic lupus erythematosus: a randomized placebo-controlled trial. EULAR 2018; Amsterdam: Abstract OP0117.
3 Oon S, Wilson, Wicks I. Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway. Clin Transl Immunology. 2016;5(5):e79.
4 Guthridge JM, Cogman A, Merrill JT, et al. Herpes Zoster Vaccination in SLE: A pilot study of immunogenicity. J Rheumatol. 2013;40(11):1875-80.
5 van der Heijde D, et al. Common language description of the term rheumatic and musculoskeletal diseases (RMDs) for use in communication with the lay public, healthcare providers and other stakeholders endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR). Annals of the Rheumatic Diseases. 2018;doi:10.1136/annrheumdis-2017-212565. [Epub ahead of print].
6 EULAR. 10 things you should know about rheumatic diseases fact sheet. Available at: https://www.eular.org/myUploadData/files/10%20things%20on%20RD.pdf [Last accessed April 2018].
European League Against Rheumatism
Related Immune System Articles:
There is a strong correlation between our fear of infection and our skepticism towards immigrants.
The bacterium Salmonella enterica causes gastroenteritis in humans and is one of the leading causes of food-borne infectious diseases.
Monash University (Australia) and Cardiff University (UK) researchers have come a step further in understanding how the human immunodeficiency virus (HIV) evades the immune system.
Eating carbohydrates during intense exercise helps to minimise exercise-induced immune disturbances and can aid the body's recovery, QUT research has found.
By studying a large protein (the C1 protein) with X-rays and electron microscopy, researchers from Aarhus University in Denmark have established a new model for how an important part of the innate immune system is activated.
Dendritic cells represent an important component of the immune system: they recognize and engulf invaders, which subsequently triggers a pathogen-specific immune response.
Researchers have seen, for the very first time, how the human immune system recognizes tuberculosis (TB).
A newly discovered protein from a fungus is able to suppress the innate immune system of plants.
Pathogen epitopes are fragments of bacterial or viral proteins. Nearly a third of all existing human epitopes consist of two different fragments.
Tuberculosis tricks the immune system into attacking the body's lung tissue so the bacteria are allowed to spread to other people, new research from the University of Southampton suggests.
Related Immune System Reading:
How the Immune System Works (The How it Works Series)
by Lauren M. Sompayrac (Author)
How the Immune System Works has helped thousands of students understand what’s in their big, thick, immunology textbooks. In his book, Dr. Sompayrac cuts through the jargon and details to reveal, in simple language, the essence of this complex subject.
In fifteen easy-to-read chapters, featuring the humorous style and engaging analogies developed by Dr. Sompayrac, How the Immune System Works explains how the immune system players work together to protect us from disease – and, most importantly, why they do it this way.
Rigorously updated for this fifth... View Details
The Immune System: A Very Short Introduction (Very Short Introductions)
by Paul Klenerman (Author)
The immune system is central to human health and the focus of much medical research. Growing understanding of the immune system, and especially the creation of immune memory (long lasting protection), which can be harnessed in the design of vaccines, have been major breakthroughs in medicine.
In this Very Short Introduction, Paul Klenerman describes the immune system, and how it works in health and disease. In particular he focuses on the human immune system, considering how it evolved, the basic rules that govern its behavior, and the major health threats where it is... View Details
The Immune System Recovery Plan: A Doctor's 4-Step Program to Treat Autoimmune Disease
by Susan Blum (Author), Mark Hyman (Foreword), Michele Bender (Foreword)
One of the most sought-after experts in the field of functional medicine shares her proven four-step program to treat, reverse, and prevent autoimmune conditions and repair your immune system.
• Are you constantly exhausted?
• Do you frequently feel sick?
• Are you hot when others are cold, or cold when everyone else is warm?
• Do you have trouble thinking clearly, aka “brain fog”?
• Do you often feel irritable?
• Are you experiencing hair loss, dry skin, or unexplained weight fluctuation?
• Do your joints ache or swell but you don’t know... View Details
The Immune System, 4th Edition
by Peter Parham (Author)
A clear, concise, and contemporary presentation of immunological conceptsThis text emphasizes the human immune system and presents concepts with a balanced level of detail to describe how the immune system works. Written for undergraduate, medical, veterinary, dental, and pharmacy students, it makes generous use of medical examples to illustrate points. This classroom-proven textbook offers clear writing, full-color illustrations, and section and chapter summaries that make the content accessible and easily understandable to students. View Details
Basic Immunology: Functions and Disorders of the Immune System, 5e
by Abul K. Abbas MBBS (Author), Andrew H. H. Lichtman MD PhD (Author), Shiv Pillai MBBS PhD (Author)
In this updated edition of Basic Immunology, the authors continue to deliver a clear, modern introduction to immunology, making this the obvious choice for today's busy students. Their experience as teachers, course directors, and lecturers helps them to distill the core information required to understand this complex field. Through the use of high-quality illustrations, relevant clinical cases, and concise, focused text, it's a perfectly accessible introduction to the workings of the human immune system, with an emphasis on clinical relevance.... View Details
Immune System: 101 Natural Ways to Boost your Immune System, Fight Germs, and Live a Healthy Life
by Living in Health (Author)
BOOST YOUR IMMUNE SYSTEM! 101 NATURAL WAYS TO BOOST YOUR IMMUNE SYSTEM, FIGHT GERMS, AND LIVE A HEALTHY LIFE Your immune system is the body’s only line of defense against both foreign and internal threats. It is clear therefore that you must maintain your immune system in the best possible condition for optimal health. It is not a myth that some foods are better than others at boosting our immunity. If you were ever wondering what might be the best foods in the world to help keep your immune system in the best shape, then this book is simply the way to go. It really helps to have a great... View Details
The Immune System, 3rd Edition
by Peter Parham (Author)
The Immune System, Third Edition emphasizes the human immune system and synthesizes immunological concepts into a comprehensible, up-to-date, and reader-friendly account of how the immune system works.
Written for undergraduate, medical, veterinary, dental, and pharmacy students in immunology courses, it makes generous use of medical examples to illustrate points.
The Third Edition has been extensively revised and updated and includes two new chapters on innate and adaptive immunity, which explore the physical, cellular, and molecular principles... View Details
The Immune System Cure: Optimize Your Immune System in 30 Days-The Natural Way!
by Lorna Vanderheaghe (Author)
What causes one person to catch a cold or flu and another to avoid it? Why do serious outbreaks of infectious diseases leave some individuals untouched? What allows someone to be incapacitated by allergies? The answer lies within nature itself-our immune system. The Immune System Cure provides simple techniques for supercharging your immune system to resist and prevent disease. Through diet, exercise, stress reduction and nutritional supplements, including plant sterols and sterolins, you can harness the power of your immune system in just 30 days and help it combat: Antibiotic-resistant... View Details
Boost Your Immune System: Strategies for Strengthening Your Immune System with Foods, Herbs, Stress Management, and More!
by Editors of Publications International Ltd. (Author)
Get and stay healthy, the natural way! Boost Your Immune System is packed with information on how to boost your immune system.
Chapter topics include sleep, stress management (meditation, exercise, gratitude, mindfulness, massage, and more), power foods, vitamins and herbs, environmental factors and preventative medicine, and home remedies for getting over common ailments quickly.
You'll learn how your immune system works, how to fine-tune it by eating certain foods and vitamins, and how your mind and body work together to produce optimal health.
4-color photography enhances the book. View Details
Immune: How Your Body Defends and Protects You (Bloomsbury Sigma)
by Catherine Carver (Author)
The human body is like an exceedingly well-fortified castle, defended by billions of soldiers--some live for less than a day, others remember battles for decades, but all are essential in protecting us from disease. This hidden army is our immune system, and without it we could not survive the eternal war between us and our microscopic enemies.
Immune explores the incredible arsenal that lives within us--how it knows what to attack and what to defend, and how it kills everything from the common cold to the plague bacterium. We see what happens when the immune system turns on... View Details